PRDX5 and Hodgkins lymphoma: In addition, there is evidence that Prdx5 is also involved in chemoresistance to adriamycin, bleomycin, vinblastine, and dacarbazine in patients of Hodgkin’s lymphoma and in vitro lung carcinoma U1810 cell lines [192].